glp-1 fda approved for pcos medications are not by the Food and Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label 💊New GLP-1 pill gets FDA

Which one suits you is a clinical judgment made with a licensed prescriber who reviews your history

Its about creating a partnership rooted in education, empathy, and tailored support

This mechanism was confirmed by the evidence that erythrocytes isolated from smokers exhibited higher levels of membrane-recruited caspase-8 and FADD than non-smokers

At Carrara, we believe GLP-1 medications may represent one of the most important breakthroughs in addiction medicine in decades, not simply because they can reduce appetite, but because many patients report a meaningful reduction in cravings, compulsive reward-seeking, and the constant mental noise surrounding alcohol, food, and other substances